Americans desperately want day-to-day life to be more affordable. Right now, they aren't getting it.
The big picture: The pinch of high prices for food, energy, housing and more has driven seismic shifts in public opinion over the last four years. Since the onset of the Iran war, the cost of living looks likely to get worse, not better, at least in the near term.
A cultural shift toward downsizing fueled by a GLP-1 drug boom and slimming celebrities is destabilizing for people trying to achieve acceptance, mental health experts and body positivity advocates tell Axios.
Why it matters: Still, the body positivity movement, advocates say, is an ongoing fight that won't shrink with the trends.
China's emergence as a second hub of pharmaceutical innovation could trigger massive changes to the global drug market, including how treatments are regulated and priced in the U.S.
Why it matters: More cutting-edge therapies are generally a good thing for patients, regardless of where they come from. But the new world order could spark questions over who'll access those therapies and where money flows.
